Paloma Partners’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-4,600
Closed -$984K 1085
2022
Q2
$984K Buy
4,600
+1,757
+62% +$429K 0.1% 430
2022
Q1
$807K Buy
2,843
+708
+33% +$218K 0.06% 521
2021
Q4
$804K Buy
+2,135
New +$829K 0.03% 827
2021
Q2
Sell
-11,670
Closed -$3.38M 1850
2021
Q1
$3.38M Buy
11,670
+10,532
+925% +$2.93M 0.1% 241
2020
Q4
$284K Sell
1,138
-3,342
-75% -$796K 0.01% 1198
2020
Q3
$1.01M Buy
4,480
+115
+3% +$23.9K 0.04% 727
2020
Q2
$761K Buy
4,365
+2,091
+92% +$334K 0.02% 1035
2020
Q1
$287K Sell
2,274
-13,909
-86% -$2.09M 0.03% 709
2019
Q4
$2.47M Buy
16,183
+14,326
+771% +$1.98M 0.06% 502
2019
Q3
$246K Buy
+1,857
New +$249K 0.01% 1646
2019
Q2
Sell
-13,969
Closed -$2.03M 1798
2019
Q1
$2.03M Buy
13,969
+10,850
+348% +$1.43M 0.07% 441
2018
Q4
$353K Sell
3,119
-4,386
-58% -$549K 0.02% 803
2018
Q3
$1.01M Buy
+7,505
New +$926K 0.03% 735
2017
Q4
Sell
-4,100
Closed -$443K 1943
2017
Q3
$443K Sell
4,100
-13,437
-77% -$1.38M 0.01% 1590
2017
Q2
$1.77M Sell
17,537
-8,932
-34% -$822K 0.05% 836
2017
Q1
$2.38M Buy
26,469
+20,331
+331% +$1.73M 0.07% 677
2016
Q4
$468K Buy
6,138
+1,600
+35% +$122K 0.01% 1538
2016
Q3
$378K Sell
4,538
-13,820
-75% -$1.16M 0.02% 1528
2016
Q2
$1.51M Buy
+18,358
New +$1.51M 0.04% 889
2016
Q1
Sell
-38,500
Closed -$3.1M 1879
2015
Q4
$3.1M Buy
38,500
+4,804
+14% +$346K 0.15% 219
2015
Q3
$2.14M Buy
33,696
+21,978
+188% +$1.58M 0.11% 317
2015
Q2
$824K Sell
11,718
-15,133
-56% -$1.12M 0.03% 854
2015
Q1
$2.13M Buy
+26,851
New +$1.98M 0.11% 286
2014
Q1
Sell
-5,612
Closed -$298K 736
2013
Q4
$298K Buy
+5,612
New +$282K 0.02% 807

Other funds holding CRL